Non-Current Liabilities

Other Non-Current Liabilities

Kailera Therapeutics Other Non-Current Liabilities decreased by 25.6% to $201.00K in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryRisk
SignalLower is better
VolatilityStable
First reportedQ4 2025
Last reportedQ1 2026May 26, 2026

How to read this metric

An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.

Detailed definition

This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...

Peer comparison

Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.

Metric ID: other_non_current_liabilities

Historical Data

2 periods
 Q4 '25Q1 '26
Value$270.00K$201.00K
QoQ Change-25.6%
Range$201.00K$270.00K

Frequently Asked Questions

What is Kailera Therapeutics 's other non-current liabilities?
Kailera Therapeutics (KLRA) reported other non-current liabilities of $201.00K in Q1 2026.
What does other non-current liabilities mean?
Miscellaneous long-term financial obligations not classified under standard debt or liability categories.